Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
sunclouds's Profile
Displaying 201-250 of 458 result(s).
CYDY CytoDyn Inc
02/02/2021 8:38:34 AM
Respect A real sad part once we hit (2)
CYDY CytoDyn Inc
01/31/2021 9:47:56 PM
MDV What in the world are you talki (17)
CYDY CytoDyn Inc
01/28/2021 9:06:02 AM
Their are many more functions neede (3)
CYDY CytoDyn Inc
01/27/2021 8:21:13 AM
The data management team does not w (7)
CYDY CytoDyn Inc
01/13/2021 7:08:02 AM
Ohm20 I am simply tying to explain (10)
CYDY CytoDyn Inc
01/12/2021 10:47:56 PM
I don't agree, the data is provided (1)
CYDY CytoDyn Inc
01/12/2021 10:45:49 PM
In my experience with being a proje (1)
CYDY CytoDyn Inc
12/15/2020 11:27:11 PM
The DMSC determines if a trial shou (4)
CYDY CytoDyn Inc
12/10/2020 9:14:30 PM
No need for DSMC review if trial if (3)
CYDY CytoDyn Inc
12/03/2020 9:18:05 AM
The FDA can only approve what is pr (7)
CYDY CytoDyn Inc
11/25/2020 2:16:38 PM
Wasn't Itolizumab, another mab from (1)
CYDY CytoDyn Inc
11/23/2020 11:43:52 AM
No mention of US HIV timeline so as
CYDY CytoDyn Inc
11/12/2020 8:59:07 PM
I would assume that it would have b
CYDY CytoDyn Inc
11/12/2020 8:49:42 AM
The info for the last loan is in SE (1)
CYDY CytoDyn Inc
11/09/2020 7:40:02 PM
That Lilly EUA is so weak and they (3)
CYDY CytoDyn Inc
11/05/2020 8:33:49 PM
FDA means FDA - not amarex IMO (1)
CYDY CytoDyn Inc
11/05/2020 8:29:47 PM
It is shocking that the clinical te (5)
CYDY CytoDyn Inc
10/27/2020 3:23:00 PM
In the US, the price for HIV will b
CYDY CytoDyn Inc
10/26/2020 3:04:50 PM
Phase 4 studies are post approval s (2)
CYDY CytoDyn Inc
10/26/2020 8:13:58 AM
There has been discussion about the (2)
CYDY CytoDyn Inc
10/21/2020 7:51:13 AM
Ohm20 The effective dilution would (2)
CYDY CytoDyn Inc
10/20/2020 10:59:38 AM
The fair market values varies based
CYDY CytoDyn Inc
10/20/2020 10:41:54 AM
Clinical trial reimbursements rates (1)
CYDY CytoDyn Inc
10/20/2020 10:32:38 AM
They did mention that sites were bu (1)
CYDY CytoDyn Inc
10/04/2020 11:40:00 AM
Will the BP manuscript be fully pee
CYDY CytoDyn Inc
09/29/2020 10:34:59 AM
Lagrange Your sarcastic posts warra
CYDY CytoDyn Inc
09/26/2020 1:24:44 PM
There is one thing that cam newton (3)
CYDY CytoDyn Inc
09/26/2020 1:09:31 PM
The dr been question about the pape (2)
CYDY CytoDyn Inc
09/24/2020 9:34:39 AM
I would say the 30% discount would (2)
CYDY CytoDyn Inc
09/23/2020 10:49:02 AM
Cydy should consider offering an in (1)
CYDY CytoDyn Inc
09/23/2020 8:29:02 AM
I double checked and see the link n
CYDY CytoDyn Inc
09/23/2020 5:57:44 AM
The PR was missing the link to the (2)
CYDY CytoDyn Inc
09/16/2020 3:38:35 PM
As far as i know is we only have on
CYDY CytoDyn Inc
09/16/2020 3:15:03 PM
None before open I am hoping for so
CYDY CytoDyn Inc
09/16/2020 9:32:39 AM
Companies do not need to rely only (6)
CYDY CytoDyn Inc
09/15/2020 9:32:36 AM
From the press resease this morning (3)
CYDY CytoDyn Inc
09/14/2020 8:42:35 PM
There is no way any IMO any company (7)
CYDY CytoDyn Inc
09/13/2020 8:25:56 PM
Thanks for all of the public and pr (4)
CYDY CytoDyn Inc
09/13/2020 12:37:47 PM
Board help please! My mother just c (1)
CYDY CytoDyn Inc
09/04/2020 11:35:43 AM
Looking forward to these yearly reu (2)
CYDY CytoDyn Inc
09/03/2020 12:28:59 PM
Reallypeople I think that you are i (1)
CYDY CytoDyn Inc
09/02/2020 9:35:55 PM
Fortuno If you just listen to the c (7)
CYDY CytoDyn Inc
09/01/2020 10:16:41 PM
JNCE got low royalty % from Gilead
CYDY CytoDyn Inc
08/31/2020 3:22:55 PM
Maybe they applied for the money Be (1)
CYDY CytoDyn Inc
08/30/2020 2:36:31 PM
I like the very soon timeframe for (1)
CYDY CytoDyn Inc
08/29/2020 8:40:25 PM
Cdiddy Great to have you back - nic (1)
CYDY CytoDyn Inc
08/28/2020 11:23:48 AM
The same team that hired an retaine (2)
CYDY CytoDyn Inc
08/28/2020 11:05:29 AM
Index guy Amarex has always been re (4)
CYDY CytoDyn Inc
08/27/2020 2:22:04 PM
Actually the article was on page B5 (1)
CYDY CytoDyn Inc
08/26/2020 9:26:14 PM
Disappointed In the WSJ. The last t (6)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Nota AI's KOSDAQ Listing Marks a New Era for AI Innovations
  • Faraday Future Expands Operations with Strategic Partnerships
  • Bitget and Fasanara Capital Unite for Enhanced Digital Asset Liquidity
  • WPP plc Investors Urged to Act Before Class Action Deadline
  • HUTCHMED Showcases Innovative Cancer Treatments at Recent Event
  • Benitec Biopharma's Latest Update: Advancing Gene Therapy Research
  • Benitec Biopharma Updates Phase 1b/2a Study for OPMD
  • HUTCHMED Advances Innovative Cancer Treatments and Pipeline
  • Join the Movement: Stand Up Against Fraud with Rosen Law
  • SAMURAI Paint Unveils Innovative Car Spray Paint Series
  • FireFly Welcomes New Non-Executive Director with Vast Industry Expertise
  • Dave Ramsey's Critique of Congressional Incompetence
  • Critical Insights on Savara Inc. and the Upcoming Class Action
  • FireFly Metals Welcomes Experienced Director to the Team
  • Discovering Innovations in Vascular Treatments from The VEINS 2025
  • Lantheus Holdings Class Action: What Investors Need to Know
  • Unveiling America's Tech Revolution: Buck Sexton's Insights
  • Alvotech Faces Challenges in Biologics License Approval Process
  • Alvotech's Progress on FDA Review for AVT05 Biosimilar
  • Secure Your Rights: Join the Avantor, Inc. Class Action
  • Latest Updates on Caribou Biosciences' CAR-T Cell Trials
  • How Tanka's AI Platform is Shaping the Future of Startups
  • Caribou Biosciences Announces Upcoming Webcast for CAR-T Data
  • Kevin O'Leary's Journey: Overcoming Failures to Find Freedom
  • The Secrets Behind A $6.5 Million Used Clothing Business Success
  • Important Legal Update for Tronox Investors: Act Now
  • Class Action Alert: Quantum Corporation Stockholder News
  • Warren Buffett's Reflective Lessons from Investment Mistakes
  • Transforming Housekeeping into a Lucrative Career Path
  • Apple's Strategic Innovations and Market Challenges Ahead
  • Snowflake's Mike Gannon Sparks SEC Filing After Influencer Talk
  • Livestrong Foundation's Annual Challenge Empowers Cancer Survivors
  • Google's Decision to Shift Women Techmakers Program Sparks Controversy
  • Podiatry Content Connection Unveils Innovative AI Solutions
  • zerohash Europe Gets MiCAR Authorization for Crypto Services
  • Tech Titans' Dinner Sparks Fried Chicken Stock Boom
  • The Rise of the Silver American Eagle: Why Stackers Are Going All In
  • Tenaris Launches $600 Million in Share Buyback for Investors
  • Kiyosaki Advocates for Bitcoin and Ethereum Amid Market Uncertainty
  • Tenaris Launches $600 Million in Share Buybacks Amid Growth
  • Exploring AI Adoption Among Small Businesses Across The U.S.
  • Shiba Inu ETF Filing Sparks Significant Token Burn Event
  • Investors of Avantor, Inc. Encouraged to Seek Justice Together
  • Al Salam Bank Commemorates ASB Capital's Successful Year
  • Tom Lee: The Trusted Face of Ethereum in the Finance World
  • Elon Musk and Sam Altman: The Roadster Refund Debate
  • Navigating Career Transitions: Insights from Industry Experts
  • Key Steps for Fortinet, Inc. Investors Ahead of Class Action
  • Air Traffic Controllers Face Staffing Crisis Amid Shutdown
  • Warren Challenges Trump on Rising Costs Affecting Families
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site